真實世界證據解決方案市場規模、佔有率和成長分析（按組件、應用、收入模式、部署類型、最終用戶和地區分類）—2026-2033年產業預測

全球真實世界證據 (RWE) 解決方案市場規模預計在 2024 年達到 18 億美元，從 2025 年的 21 億美元成長到 2033 年的 73.4 億美元，在預測期（2026-2033 年）內複合年成長率為 16.9%。

全球真實世界數據 (RWE) 解決方案在核准後安全性監測中已廣泛應用，並加速融入藥物研發生命週期，尤其是在藥物療效評估方面。許多國家正在利用 RWE 進行藥物監測和上市後評估。政府的支持性政策和產業聯盟的努力預計將進一步推動 RWE 應用領域的市場成長和創新。技術進步，特別是人工智慧 (AI) 和機器學習領域的進步，正在透過增強即時數據收集和分析能力來變革這一領域。這些技術能夠從海量資料集中快速獲取洞察，使研究人員和醫療保健專業人員能夠識別真實世界資料中的模式和趨勢。這有助於改善臨床決策，並最終促進藥物研發和患者照護效果的提升。

全球真實世界證據解決方案市場促進因素

全球真實世界證據解決方案市場正受到人工智慧整合的顯著推動，人工智慧使製藥和生物技術公司能夠更有效地產生有價值的真實世界證據。該技術簡化了從各種資料來源（包括歷史臨床試驗資料和真實世界資料集）中提取見解的流程。借助人工智慧驅動的分析和自動化，企業可以更全面地了解其研究，加快決策速度，並提高臨床試驗的整體效率。因此，人工智慧與真實世界數據的結合正在改變臨床研究格局，並推動市場成長。

限制全球真實世界證據解決方案市場的因素

全球真實世界證據解決方案市場面臨的一大挑戰是缺乏能夠運用新興數位技術的合格專業人員。臨床研究領域的這一人才缺口阻礙了先進數位解決方案在臨床試驗中的有效應用和實施。因此，它阻礙了產業發展，使各機構無法充分利用先進技術的潛力來提升研究能力和改善整體結果。解決此技能短缺問題對於市場的蓬勃發展以及最大程度地發揮真實世界證據解決方案的優勢至關重要。

全球真實世界證據解決方案市場趨勢

全球真實世界證據解決方案市場正呈現一個顯著趨勢：生命科學領域對全面資料利用的需求日益成長，推動了端到端服務需求的提升。相關人員致力於提供涵蓋所有階段的整合解決方案，從研究規劃和通訊協定製定到管理和報告。這種綜合方法使企業能夠有效利用真實世界數據，在產品生命週期內做出明智的決策，從而促進從研發到商業化的平穩過渡。因此，這一趨勢表明，效率、創新和策略洞察力正日益成為該領域的優先事項。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球真實世界證據解決方案市場規模（按組件和複合年成長率分類）（2026-2033 年）

• 服務
• 資料集
  • 異質資料集
  • 臨床實踐資料集
  • 計費資料集
  • 藥房資料集
  • 患者主導資料集
  • 基於註冊表的資料集
  • 整合資料集

全球真實世界證據解決方案市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 藥物研發與核准
  • 腫瘤學
  • 循環系統疾病
  • 神經病學
  • 免疫學
  • 其他治療領域
• 醫療設備開發和核准
• 上市後監測
• 市場進入/報銷/保險範圍決策
• 臨床和監管決策

全球真實世界證據解決方案市場規模（按收入模式和複合年成長率分類）（2026-2033 年）

• 付費使用制（基於價值的定價）
• 訂閱

全球真實世界證據解決方案市場規模（按部署模式和複合年成長率分類）（2026-2033 年）

• 本地部署
• 基於雲端的

全球真實世界證據解決方案市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 醫療相關企業（製藥、生物製藥、醫療設備）
  • 臨床研究
  • 商業的
  • HEOR
  • 其他
• 醫療保險公司
• 醫療保健提供者
• 其他

全球真實世界證據解決方案市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• IQVIA Holdings（USA）
• Syneos Health（USA）
• ICON plc（Ireland）
• Cognizant Technology Solutions Corporation（USA）
• Oracle Corporation（USA）
• SAS Institute Inc.（USA）
• Elevance Health Inc.（USA）
• Clinigen Group plc（UK）
• Cegedim Health Data（France）
• Verantos（USA）
• HealthVerity Inc.（USA）
• Datavant（USA）
• Syapse Inc.（USA）
• Tempus（USA）
• Flatiron Health（USA）
• PerkinElmer Inc.（USA）
• Trinity（USA）
• Aetion Inc.（USA）

結論與建議

Global Real-World Evidence Solutions Market size was valued at USD 1.80 Billion in 2024 and is poised to grow from USD 2.1 Billion in 2025 to USD 7.34 Billion by 2033, growing at a CAGR of 16.9% during the forecast period (2026-2033).

Global Real-World Evidence (RWE) solutions have seen significant adoption for post-approval safety surveillance and are increasingly integrated into the drug development lifecycle, particularly for assessing drug efficacy. Many countries leverage RWE for pharmacovigilance and post-marketing evaluations. Supportive government initiatives and industry coalitions are expected to further spur market growth and innovation in RWE applications. Technological advancements, particularly in Artificial Intelligence and Machine Learning, are transforming the field by enhancing real-time data collection and analysis. These technologies enable rapid insights from extensive datasets, allowing researchers and healthcare professionals to identify patterns and trends in real-world data. This leads to improved decision-making in clinical contexts, ultimately enhancing drug development and patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Real-World Evidence Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Real-World Evidence Solutions Market Segments Analysis

Global Real World Evidence Solutions Market is segmented by Component, Application, Revenue Model, Deployment Mode, End User and region. Based on Component, the market is segmented into Services and Data Sets. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Post-Market Surveillance, Market Access & Reimbursement/Coverage Decision-Making and Clinical & Regulatory Decision-Making. Based on Revenue Model, the market is segmented into Pay Per Use (Value-Based Pricing) and Subscription. Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End User, the market is segmented into Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device), Healthcare Payers, Healthcare Providers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Real-World Evidence Solutions Market

The Global Real-World Evidence Solutions market is significantly propelled by the integration of artificial intelligence, which empowers pharmaceutical and biotech companies to enhance their generation of valuable real-world evidence. This technology streamlines the process of extracting insights from a variety of data sources, including historical clinical trial data and real-world datasets. By utilizing AI-driven analytics and automation, companies can achieve a more comprehensive understanding of their research, facilitating quicker decision-making and improving the overall effectiveness of clinical trials. As a result, the combination of AI and real-world data is transforming the landscape of clinical research, driving growth within the market.

Restraints in the Global Real-World Evidence Solutions Market

A significant challenge facing the Global Real-World Evidence Solutions market is the shortage of qualified professionals adept at navigating new digital technologies. This workforce gap within the clinical research sector hinders the effective adoption and implementation of sophisticated digital solutions in clinical trials. As a result, the industry's growth is stifled, as organizations struggle to leverage the full potential of advanced technologies that could enhance their research capabilities and improve overall outcomes. Bridging this skills deficit is crucial for the market to thrive and fully capitalize on the benefits offered by real-world evidence solutions.

Market Trends of the Global Real-World Evidence Solutions Market

The Global Real-World Evidence Solutions market is witnessing a notable trend towards the increasing demand for end-to-end services, driven by the need for comprehensive data utilization across the life sciences spectrum. Stakeholders are focusing on providing integrated solutions that encompass every stage, from study planning and protocol development to management and reporting. This holistic approach enables organizations to leverage real-world data effectively to make informed, evidence-based decisions throughout the entire lifecycle of a product, facilitating smoother transitions from research and development to commercialization. Consequently, this trend underscores the growing prioritization of efficiency, innovation, and strategic insights in the sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Real World Evidence Solutions Market Size by Component & CAGR (2026-2033)

• Market Overview
• Services
• Data Sets
  • Disparate Data Sets
  • Clinical Settings Data Sets
  • Claims Data Sets
  • Pharmacy Data Sets
  • Patient-Powered Data Sets
  • Registry-Based Data Sets
  • Integrated Data Sets

Global Real World Evidence Solutions Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Other Therapeutic Areas
• Medical Device Development & Approvals
• Post-Market Surveillance
• Market Access & Reimbursement/Coverage Decision-Making
• Clinical & Regulatory Decision-Making

Global Real World Evidence Solutions Market Size by Revenue Model & CAGR (2026-2033)

• Market Overview
• Pay Per Use (Value-Based Pricing)
• Subscription

Global Real World Evidence Solutions Market Size by Deployment Mode & CAGR (2026-2033)

• Market Overview
• On-Premise
• Cloud-Based

Global Real World Evidence Solutions Market Size by End User & CAGR (2026-2033)

• Market Overview
• Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device)
  • Clinical research
  • Commercial
  • HEOR
  • Others
• Healthcare Payers
• Healthcare Providers
• Others

Global Real World Evidence Solutions Market Size & CAGR (2026-2033)

• North America (Component, Application, Revenue Model, Deployment Mode, End User)
  • US
  • Canada
• Europe (Component, Application, Revenue Model, Deployment Mode, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Application, Revenue Model, Deployment Mode, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Application, Revenue Model, Deployment Mode, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Application, Revenue Model, Deployment Mode, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IQVIA Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant Technology Solutions Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elevance Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegedim Health Data (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verantos (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthVerity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Datavant (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syapse Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aetion Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations